Leg ulcers in sickle cell disease: Current patterns and practices

Hemoglobin

Volumn 37, Issue 4, 2013, Pages 325-332

  Delaney, Kara Marie H ^a   Axelrod, Karen C ^a   Buscetta, Ashley ^a   Hassell, Kathryn L ^b   Adams Graves, Patricia E ^c   Seamon, Catherine ^a   Kato, Gregory J ^a   Minniti, Caterina P ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b Colorado Sickle Cell Center ^*  (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Hydroxyurea (HU); Leg Ulcers; Sickle cell disease; Survey

Indexed keywords

HEMOGLOBIN C; HEMOGLOBIN S; HYDROXYUREA; ZINC SULFATE;

ADULT; ARTICLE; BLOOD TRANSFUSION; COMPRESSION STOCKING; CONSULTATION; DEBRIDEMENT; DERMATOLOGY; DISEASE SURVEILLANCE; FEMALE; GENOTYPE; HUMAN; INCIDENCE; LEG ULCER; MAJOR CLINICAL STUDY; MALE; PLASTIC SURGERY; PODIATRY; SEX RATIO; SHOE; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HEALTH CARE SURVEYS; HEALTH PERSONNEL; HEMOGLOBIN, SICKLE; HUMANS; LEG ULCER; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; UNITED STATES; YOUNG ADULT;

EID: 84879806260     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2013.789968     Document Type: Article

References (32)

1. Herrick JB. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910. Yale J Biol Med. 2001;74(3):179-184.
2. Eckman JR. Leg ulcers in sickle cell disease. Hematol Oncol Clin North Am. 1996;10(6):1333-1344.
3. Koshy M, Entsuah R, Koranda A, et al. Leg ulcers in patients with sickle cell disease. Blood. 1989;74 (4):1403-1408.
4. Serjeant GR. Leg ulceration in sickle cell anemia. Arch Intern Med. 1974;133(4):690-694.
5. Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SK. Leg ulcers in sickle cell disease. Am J Hematol. 2010;85(10):831-833.
6. Parent F, Bachir D, Inamo J, et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med. 2011;365(1):44-53.
7. Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006;107(6):2279-2285.
8. Nolan VG, Adewoye A, Baldwin C, et al. Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Br J Haematol. 2006;133(5):570-578.
9. Halabi-Tawil M, Lionnet F, Girot R, Bachmeyer C, Levy PP, Aractingi S. Sickle cell leg ulcers: a frequently disabling complication and a marker of severity. Br J Dermatol. 2008;158(2):339-344.
10. Borgna-Pignatti C, Marsella M, Zanforlin N. The natural history of thalassemia intermedia. Ann NY Acad Sci. 2010;1202:214-220.
11. Giraldi S, Abbage KT, Marinoni LP, et al. Leg ulcer in hereditary spherocytosis. Pediatr Dermatol. 2003;20(5):427-428.
12. Muller-Soyano A, Tovar de Roura E, Duke PR, et al. Pyruvate kinase deficiency and leg ulcers. Blood. 1976;47(5):807-813.
13. Powars DR. Sickle cell anemia and major organ failure. Hemoglobin. 1990;14(6):573-598.
14. Minniti CP, Taylor JG, Hildesheim M, et al. Laboratory and echocardiography markers in sickle cell patients with leg ulcers. Am J Hematol. 2011;86(8):705-708.
15. Marti-Carvajal AJ, Knight-Madden JM, Martinez-Zapata MJ. Interventions for treating leg ulcers in people with sickle cell disease. Cochrane Database Syst Rev. 2012;11:CD008394.
16. Nguyen TV, Margolis DJ. Hydroxyurea and lower leg ulcers. Cutis. 1993;52(4):217-219.
17. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332(20):1317-1322.
18. Lansdown AB. Zinc in the healing wound. Lancet. 1996;347(9003):706-707.
19. Serjeant GR, Galloway RE, Gueri MC. Oral zinc sulphate in sickle-cell ulcers. Lancet. 1970;2 (7679):891-892.
20. O'Meara S, Cullum NA, Nelson EA. Compression for venous leg ulcers. Cochrane Database Syst Rev. 2009(1):CD000265.
21. Abisi S, Tan J, Burnand KG. Excision and meshed skin grafting for leg ulcers resistant to compression therapy. Br J Surg. 2007;94(2):194-197.
22. Dumville JC, Worthy G, Bland JM, et al. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. BMJ. 2009;338:b773.
23. Paul AG, Ahmad NW, Lee HL, et al. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers. Int Wound J. 2009;6(1):39-46.
24. Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2004(2):CD004123.
25. Londahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010;33(5):998-1003.
26. Mery L, Girot R, Aractingi S. Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers. Dermatology. 2004;208(2):135-137.
27. Wethers DL, Ramirez GM, Koshy M, et al. Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study Group. Blood. 1994;84(6):1775-1779.
28. McMahon L, Tamary H, Askin M, et al. A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers. Br J Haematol. 2010;151(5):516-524.
29. Perrine RP, Pembrey ME, John P, Perrine S, Shoup F. Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects. Ann Intern Med. 1978;88(1):1-6.
30. Kersgard C, Osswald MB. Hydroxyurea and sickle cell leg ulcers. Am J Hematol. 2001;68(3):215-216.
31. Sirieix ME, Debure C, Baudot N, et al. Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol. 1999;135(7):818-820.
32. Trent JT, Kirsner RS. Leg ulcers in sickle cell disease. Adv Skin Wound Care. 2004;17(8):410-416.